MikroScore
Transparent product review

Product Review

Tru Niagen NR 300

ChromaDex / Tru Niagen · Capsule · 300 mg

Price/day

€0.83

Dose

300 mg

Servings/pack

60

Pack price

€49.95

NSF Certified

Transparency Index

7.3/10

Recommended The quality benchmark for NR. If you value independent certification and direct study evidence, this is the right choice — despite a comparatively high price per mg.

Rating breakdown

Evidence for ingredient 6.0/10

NR is the best-researched NAD+ precursor with multiple RCTs. Tru Niagen has been directly investigated in its own human studies.

Value for money 5.0/10

€0.83 per day for just 300 mg. NMN is often cheaper at higher doses. Premium price for a patented substance.

Product quality 8.0/10

Patented Niagen ingredient (ChromaDex). NSF-certified. Consistent quality across all batches. Stable product.

Label honesty 8.0/10

Marketing claims remain close to the available study evidence. No exaggerated anti-aging promises.

Third-party testing 8.0/10

NSF Certified for Sport. Independent third-party verification of purity and label accuracy.

Product Description

Tru Niagen is the flagship product of ChromaDex, the company that patented nicotinamide riboside (NR) under the brand name Niagen. Multiple clinical studies have been conducted directly with this product.

What We Like

  • NSF Certified for Sport: Independent third-party certification — the gold standard for supplement quality
  • Direct study evidence: Tru Niagen itself has been investigated in human studies, not just the ingredient in general
  • Patented ingredient: Niagen by ChromaDex is the best-characterized NR form on the market
  • Consistent quality: Years of market presence with no known quality issues

What We’re Missing

  • Price per mg: Expensive compared to NMN products for the delivered dose
  • Availability in Germany: Not always directly available; often requires import from UK/US
  • 300 mg dose: Some studies used 500–1000 mg daily

Ingredient dossier

Like NMN, NR is a NAD+ precursor — but unlike NMN, it is approved as a Novel Food in the EU. Human studies confirm NAD+ elevation; clinical benefits remain unclear.

Read full dossier: NR (Nicotinamide Riboside) →